Adenocarcinomas News and Research

RSS
Three early-phase clinical studies show promising initial data for patients with lymphoma, gastric cancers

Three early-phase clinical studies show promising initial data for patients with lymphoma, gastric cancers

New lung cell atlas unveils pathways to lung adenocarcinoma development

New lung cell atlas unveils pathways to lung adenocarcinoma development

Next-generation sequencing and machine learning used to map genetic landscape of pancreatic cancer

Next-generation sequencing and machine learning used to map genetic landscape of pancreatic cancer

New mouse model illuminates lung cancer's transformation into aggressive variant

New mouse model illuminates lung cancer's transformation into aggressive variant

Study reveals mangos attenuates potential against colon cancer

Study reveals mangos attenuates potential against colon cancer

Closing the gap: PATROL's approach to overcoming lung cancer diagnostic inequality

Closing the gap: PATROL's approach to overcoming lung cancer diagnostic inequality

Organoid study opens new avenues in pulmonary neuroendocrine cancer therapy

Organoid study opens new avenues in pulmonary neuroendocrine cancer therapy

Could the microbiome hold the key to diagnosing and treating biliary tract cancer?

Could the microbiome hold the key to diagnosing and treating biliary tract cancer?

Modified adenocarcinoma classification improves reproducibility and aligns with clinical reality

Modified adenocarcinoma classification improves reproducibility and aligns with clinical reality

Study discovers new mechanism for deadly tumor switch in prostate cancer

Study discovers new mechanism for deadly tumor switch in prostate cancer

Addressing research gaps: The UK's efforts to study lung cancer in never smokers

Addressing research gaps: The UK's efforts to study lung cancer in never smokers

Single-cell RNA sequencing provides new insights into gastric cancer

Single-cell RNA sequencing provides new insights into gastric cancer

Lipid-degrading enzyme, fatty acid amide hydrolase is a predictor of long-term survival in patients with breast cancer

Lipid-degrading enzyme, fatty acid amide hydrolase is a predictor of long-term survival in patients with breast cancer

Could personalized neoantigen vaccines prevent the recurrence of pancreatic cancer and increase patient survival?

Could personalized neoantigen vaccines prevent the recurrence of pancreatic cancer and increase patient survival?

New CRISPR genome-editing technology helps scientists to explore many cancer-linked mutations

New CRISPR genome-editing technology helps scientists to explore many cancer-linked mutations

The potential anti-cancer and antioxidant properties of walnuts

The potential anti-cancer and antioxidant properties of walnuts

Detecting tissue-resident memory T cells in solid tumors

Detecting tissue-resident memory T cells in solid tumors

Scientists generate 3D ultra-resolution maps of mitochondrial networks in lung tumors

Scientists generate 3D ultra-resolution maps of mitochondrial networks in lung tumors

Difference between human and mouse lung tumor cells explains the discrepancy in cancer drug results

Difference between human and mouse lung tumor cells explains the discrepancy in cancer drug results

Researchers use multiplexed 3D imaging to perform molecular and morphological assessments of colorectal cancers

Researchers use multiplexed 3D imaging to perform molecular and morphological assessments of colorectal cancers

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.